Noticias de BTAI_US

Noticias del mercado

Últimas noticias sobre BTAI_US — 179 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BTAI_US ✕ 179 resultados
17/04/2026 BTAI_US — Investing.com
BioXcel Therapeutics issues warrants to lenders as part of credit agreement amendment
17/04/2026 BTAI_US — ChartMill
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
17/04/2026 BTAI_US — GlobeNewswire
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
17/04/2026 BTAI_US — HarianBasis.co
BioXcel Therapeutics Advances Clinical Studies for Acute Stress Treatment
17/04/2026 BTAI_US — Investing.com
BioXcel to detail IGALMI launch strategy ahead of FDA decision
17/04/2026 BTAI_US — Investing.com
BioXcel to detail IGALMI launch strategy ahead of FDA decision
17/04/2026 BTAI_US — TipRanks
Bioxcel Issues Warrants in Private Equity Financing Deal
17/04/2026 BTAI_US — Stock Titan
86M annual at-home agitation episodes shape BioXcel's IGALMI plan
13/04/2026 BTAI_US — Yahoo Finance
How The BioXcel Therapeutics (BTAI) Story Is Shifting With BXCL501 Promise And Dilution Risks
09/04/2026 BTAI_US — GuruFocus
Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary D
09/04/2026 BTAI_US — PR Newswire
Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
08/04/2026 BTAI_US — GlobeNewswire
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
08/04/2026 BTAI_US — Yahoo Finance
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
08/04/2026 BTAI_US — Stock Titan
BioXcel drug enters U.S. military-funded study for acute stress after trauma
08/04/2026 BTAI_US — RTTNews
BioXcel Therapeutics Begins Enrollment In DoW-Funded Study Of BXCL501 For Acute Stress Reactions
08/04/2026 BTAI_US — MarketScreener
BioXcel Therapeutics announces enrollment of first patients in U.S. Department of War-funded study of BXCL501 (sublingual dexmedetomidine) for treatment of acute stress reactions
04/04/2026 BTAI_US — Intellectia AI
BTAI Technical Analysis & Stock Price Forecast

Obtenga análisis técnicos BTAI, promedios móviles, indicadores RSI y MACD en tiempo real. Vea pronósticos de acciones profesionales y señales de compra/venta.

02/04/2026 BTAI_US — Investing.com ES ← EN
H.C. Wainwright recorta el precio objetivo de BioXcel Therapeutics por dilución Por Investing.com
02/04/2026 BTAI_US — Investing.com
H.C. Wainwright cuts BioXcel Therapeutics price target on dilution
01/04/2026 BTAI_US — GlobeNewswire
BioXcel Therapeutics Announces Food & Drug Administration

Página 7 de 9

keyboard_arrow_up